The patients were randomly allocated into two groups , and during EIS sessions , one group was administered proton pump inhibitor ( PPI ) ( Rabeprazole 20 mg a person once a day ) , while the other received histamine H2 receptor antagonist ( H2-blocker ) ( famotidine 20 mg a person , twice a day ) .